| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.945 | 0.003 | 0.945 | Aldehyde oxidase inhibitor | 0.409 0.046 CID_154699841 | ||
| 0.855 | 0.005 | 0.872 | Caspase 9 stimulant | 0.872 0.004 CID_154699841 | CID_154699841 | |
| 0.814 | 0.012 | 0.916 | Transcription factor NF kappa B inhibitor | 0.916 0.005 CID_154699841 | CID_154699841 | |
| 0.721 | 0.002 | 0.721 | Aromatase inhibitor | 0.11 0.02 CID_154699841 | ||
| 0.716 | 0.007 | 0.871 | Cholesterol antagonist | 0.871 0.003 CID_154699841 | CID_154699841 | |
| 0.725 | 0.027 | 0.768 | Apoptosis agonist | 0.768 0.02 CID_154699841 | CID_154699841 | |
| 0.719 | 0.027 | 0.822 | Antiinflammatory | 0.822 0.013 CID_154699841 | CID_154699841 | |
| 0.69 | 0.002 | 0.69 | Estrogen receptor alpha antagonist | 0.087 0.038 CID_154699841 | ||
| 0.685 | 0.003 | 0.685 | Estrogen agonist | 0.537 0.003 CID_154699841 | ||
| 0.681 | 0.005 | 0.723 | Hypoxia-inducible factor 1 alpha inhibitor | 0.723 0.004 CID_154699841 | CID_154699841 | |
| 0.674 | 0.004 | 0.674 | Anesthetic general | 0.633 0.004 CID_154699841 | ||
| 0.58 | 0.003 | 0.58 | Androgen antagonist | 0.158 0.02 CID_154699841 | ||
| 0.584 | 0.009 | 0.584 | DNA damaging | 0.572 0.009 CID_154699841 | ||
| 0.577 | 0.002 | 0.577 | Estradiol 17 beta-dehydrogenase inhibitor | 0.053 0.023 CID_154699841 | ||
| 0.568 | 0.002 | 0.568 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.028 0.01 CID_154699841 | ||
| 0.563 | 0.004 | 0.563 | Estrogen antagonist | 0.303 0.006 CID_154699841 | ||
| 0.55 | 0.003 | 0.55 | Neurotrophic factor enhancer | 0.504 0.004 CID_154699841 | ||
| 0.546 | 0.003 | 0.546 | Lipocortins synthesis antagonist | 0.445 0.006 CID_154699841 | ||
| 0.551 | 0.014 | 0.551 | Caspase 3 stimulant | 0.505 0.019 CID_154699841 | ||
| 0.553 | 0.02 | 0.608 | 5 Hydroxytryptamine release stimulant | 0.608 0.014 CID_154699841 | CID_154699841 | |
| 0.529 | 0.002 | 0.529 | Androgen agonist | 0.202 0.005 CID_154699841 | ||
| 0.528 | 0.005 | 0.528 | NOS3 expression enhancer | 0.483 0.005 CID_154699841 | ||
| 0.522 | 0.002 | 0.522 | Keratolytic | 0.197 0.009 CID_154699841 | ||
| 0.514 | 0.005 | 0.514 | Adenylate cyclase inhibitor | 0.322 0.011 CID_154699841 | ||
| 0.516 | 0.025 | 0.516 | Vasodilator, peripheral | 0.423 0.048 CID_154699841 | ||
| 0.5 | 0.012 | 0.5 | Antimitotic | 0.273 0.052 CID_154699841 | ||
| 0.488 | 0.004 | 0.488 | Sodium/bile acid cotransporter inhibitor | 0.419 0.012 CID_154699841 | ||
| 0.498 | 0.021 | 0.622 | Apoptosis antagonist | 0.622 0.008 CID_154699841 | CID_154699841 | |
| 0.485 | 0.009 | 0.485 | P-glycoprotein inhibitor | 0.369 0.019 CID_154699841 | ||
| 0.48 | 0.009 | 0.596 | Diuretic | 0.596 0.005 CID_154699841 | CID_154699841 | |
| 0.471 | 0.001 | 0.471 | Estrogen-related receptor beta agonist | 0.137 0.005 CID_154699841 | ||
| 0.502 | 0.032 | 0.582 | Immunosuppressant | 0.582 0.015 CID_154699841 | CID_154699841 | |
| 0.482 | 0.017 | 0.548 | Nitric oxide antagonist | 0.548 0.013 CID_154699841 | CID_154699841 | |
| 0.435 | 0.001 | 0.435 | Anabolic | 0.222 0.003 CID_154699841 | ||
| 0.442 | 0.009 | 0.534 | Interferon gamma antagonist | 0.534 0.004 CID_154699841 | CID_154699841 | |
| 0.434 | 0.014 | 0.599 | Interleukin agonist | 0.599 0.005 CID_154699841 | CID_154699841 | |
| 0.422 | 0.004 | 0.422 | Beta tubulin antagonist | 0.116 0.018 CID_154699841 | ||
| 0.43 | 0.015 | 0.43 | Calcium channel activator | |||
| 0.449 | 0.038 | 0.748 | Antithrombotic | 0.748 0.006 CID_154699841 | CID_154699841 | |
| 0.422 | 0.011 | 0.422 | Tubulin antagonist | 0.155 0.055 CID_154699841 | ||
| 0.415 | 0.004 | 0.415 | Alpha tubulin antagonist | 0.096 0.016 CID_154699841 | ||
| 0.418 | 0.007 | 0.568 | Alkylator | 0.568 0.004 CID_154699841 | CID_154699841 | |
| 0.411 | 0.002 | 0.411 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.434 | 0.029 | 0.631 | Antioxidant | 0.631 0.009 CID_154699841 | CID_154699841 | |
| 0.402 | 0.004 | 0.402 | Cholesterol synthesis inhibitor | 0.334 0.008 CID_154699841 | ||
| 0.386 | 0.003 | 0.386 | Estrogen receptor alpha agonist | 0.148 0.005 CID_154699841 | ||
| 0.385 | 0.002 | 0.385 | 5-Alpha-reductase inhibitor | 0.281 0.004 CID_154699841 | ||
| 0.377 | 0.003 | 0.377 | Estrogen receptor beta agonist | 0.193 0.005 CID_154699841 | ||
| 0.361 | 0.003 | 0.361 | Pregnane X receptor agonist | |||
| 0.37 | 0.013 | 0.37 | Phospholipase C inhibitor | 0.183 0.058 CID_154699841 | ||
| 0.36 | 0.003 | 0.36 | Progesterone antagonist | |||
| 0.357 | 0.005 | 0.357 | Estrogen receptor beta antagonist | 0.126 0.026 CID_154699841 | ||
| 0.377 | 0.025 | 0.512 | DNA synthesis inhibitor | 0.512 0.013 CID_154699841 | CID_154699841 | |
| 0.358 | 0.011 | 0.358 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.229 0.053 CID_154699841 | ||
| 0.357 | 0.018 | 0.562 | Hepatoprotectant | 0.562 0.005 CID_154699841 | CID_154699841 | |
| 0.367 | 0.028 | 0.379 | Psychostimulant | 0.379 0.026 CID_154699841 | CID_154699841 | |
| 0.349 | 0.013 | 0.449 | Lipid peroxidase inhibitor | 0.449 0.007 CID_154699841 | CID_154699841 | |
| 0.346 | 0.012 | 0.449 | Protein kinase stimulant | 0.449 0.005 CID_154699841 | CID_154699841 | |
| 0.332 | 0.002 | 0.332 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 CID_154699841 | ||
| 0.347 | 0.02 | 0.446 | Platelet adhesion inhibitor | 0.446 0.008 CID_154699841 | CID_154699841 | |
| 0.356 | 0.031 | 0.356 | Transcription factor STAT3 inhibitor | 0.198 0.137 CID_154699841 | ||
| 0.38 | 0.056 | 0.57 | Immunostimulant | 0.57 0.02 CID_154699841 | CID_154699841 | |
| 0.327 | 0.015 | 0.532 | Amylase inhibitor | 0.532 0.005 CID_154699841 | CID_154699841 | |
| 0.328 | 0.019 | 0.462 | Melanin inhibitor | 0.462 0.009 CID_154699841 | CID_154699841 | |
| 0.333 | 0.026 | 0.333 | Growth hormone agonist | |||
| 0.31 | 0.005 | 0.31 | Farnesoid X receptor antagonist | 0.169 0.035 CID_154699841 | ||
| 0.305 | 0.002 | 0.305 | RNA-directed RNA polymerase stimulant | 0.262 0.002 CID_154699841 | ||
| 0.349 | 0.046 | 0.437 | Interleukin 2 agonist | 0.437 0.018 CID_154699841 | CID_154699841 | |
| 0.3 | 0.002 | 0.3 | Arachidonic acid antagonist | 0.246 0.006 CID_154699841 | ||
| 0.301 | 0.003 | 0.301 | Adenylate cyclase stimulant | 0.2 0.014 CID_154699841 | ||
| 0.296 | 0.002 | 0.296 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.293 | 0.002 | 0.293 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.068 0.023 CID_154699841 | ||
| 0.329 | 0.041 | 0.339 | Hypolipemic | 0.339 0.038 CID_154699841 | CID_154699841 | |
| 0.288 | 0.003 | 0.288 | Bile acid receptor antagonist | 0.127 0.014 CID_154699841 | ||
| 0.301 | 0.017 | 0.301 | Bone formation stimulant | 0.212 0.033 CID_154699841 | ||
| 0.285 | 0.004 | 0.285 | Prolactin inhibitor | |||
| 0.325 | 0.044 | 0.325 | Transcription factor STAT inhibitor | |||
| 0.282 | 0.003 | 0.282 | Aldosterone antagonist | |||
| 0.275 | 0.003 | 0.275 | Glycine receptor agonist | 0.251 0.003 CID_154699841 | ||
| 0.276 | 0.004 | 0.276 | Microtubule formation inhibitor | 0.273 0.004 CID_154699841 | ||
| 0.376 | 0.105 | 0.677 | Cyclophilin D inhibitor | 0.677 0.016 CID_154699841 | CID_154699841 | |
| 0.258 | 0.002 | 0.258 | 5-Alpha-reductase 2 inhibitor | 0.043 0.008 CID_154699841 | ||
| 0.305 | 0.051 | 0.591 | Hypoglycemic | 0.591 0.009 CID_154699841 | CID_154699841 | |
| 0.292 | 0.039 | 0.292 | Gastrin inhibitor | 0.255 0.073 CID_154699841 | ||
| 0.32 | 0.072 | 0.414 | Vasodilator, coronary | 0.414 0.031 CID_154699841 | CID_154699841 | |
| 0.29 | 0.054 | 0.489 | Free radical scavenger | 0.489 0.017 CID_154699841 | CID_154699841 | |
| 0.238 | 0.01 | 0.499 | Cyclooxygenase 3 inhibitor | 0.499 0.003 CID_154699841 | CID_154699841 | |
| 0.249 | 0.025 | 0.249 | Antipruritic | 0.146 0.099 CID_154699841 | ||
| 0.231 | 0.015 | 0.469 | Expectorant | 0.469 0.004 CID_154699841 | CID_154699841 | |
| 0.275 | 0.059 | 0.629 | Angiogenesis stimulant | 0.629 0.005 CID_154699841 | CID_154699841 | |
| 0.281 | 0.078 | 0.308 | Spasmolytic | 0.308 0.067 CID_154699841 | CID_154699841 | |
| 0.204 | 0.013 | 0.204 | Antineoplastic alkaloid | 0.097 0.049 CID_154699841 | ||
| 0.237 | 0.049 | 0.394 | Non-steroidal antiinflammatory agent | 0.394 0.014 CID_154699841 | CID_154699841 | |
| 0.194 | 0.013 | 0.194 | Acetylcholine nicotinic antagonist | |||
| 0.282 | 0.102 | 0.331 | Angiogenesis inhibitor | 0.331 0.079 CID_154699841 | CID_154699841 | |
| 0.252 | 0.074 | 0.38 | Tumour necrosis factor alpha release inhibitor | 0.38 0.03 CID_154699841 | CID_154699841 | |
| 0.247 | 0.07 | 0.335 | Vasodilator | 0.335 0.038 CID_154699841 | CID_154699841 | |
| 0.174 | 0.003 | 0.174 | Estrone sulfatase inhibitor | 0.109 0.004 CID_154699841 | ||
| 0.185 | 0.017 | 0.185 | Mucolytic | 0.177 0.02 CID_154699841 | ||
| 0.205 | 0.038 | 0.26 | Interleukin 6 antagonist | 0.26 0.021 CID_154699841 | CID_154699841 | |
| 0.168 | 0.005 | 0.18 | Glycine receptor antagonist | 0.18 0.004 CID_154699841 | CID_154699841 | |
| 0.165 | 0.018 | 0.165 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 CID_154699841 | ||
| 0.148 | 0.006 | 0.161 | Na+ K+ transporting ATPase inhibitor | 0.161 0.004 CID_154699841 | CID_154699841 | |
| 0.215 | 0.079 | 0.215 | RNA-directed DNA polymerase inhibitor | 0.205 0.093 CID_154699841 | ||
| 0.23 | 0.096 | 0.23 | Cardiotonic | |||
| 0.136 | 0.002 | 0.136 | Adenylate cyclase 1 inhibitor | |||
| 0.269 | 0.142 | 0.5 | Histamine release inhibitor | 0.5 0.029 CID_154699841 | CID_154699841 | |
| 0.145 | 0.019 | 0.145 | ABCA1 expression enhancer | 0.085 0.076 CID_154699841 | ||
| 0.129 | 0.005 | 0.129 | Potassium channel Kv1.3 blocker | |||
| 0.294 | 0.172 | 0.336 | 5 Hydroxytryptamine release inhibitor | 0.336 0.128 CID_154699841 | CID_154699841 | |
| 0.165 | 0.045 | 0.165 | Cholinergic antagonist | |||
| 0.149 | 0.031 | 0.149 | TRPA1 agonist | 0.101 0.086 CID_154699841 | ||
| 0.16 | 0.044 | 0.16 | Anesthetic local | |||
| 0.159 | 0.044 | 0.166 | DNA polymerase I inhibitor | 0.166 0.041 CID_154699841 | CID_154699841 | |
| 0.158 | 0.046 | 0.158 | Acetylcholine antagonist | |||
| 0.114 | 0.004 | 0.114 | Glucocorticoid antagonist | 0.068 0.009 CID_154699841 | ||
| 0.114 | 0.006 | 0.114 | Mineralocorticoid receptor antagonist | 0.048 0.034 CID_154699841 | ||
| 0.153 | 0.046 | 0.366 | Monophenol monooxygenase inhibitor | 0.366 0.013 CID_154699841 | CID_154699841 | |
| 0.141 | 0.034 | 0.244 | AMP-activated protein kinase stimulant | 0.244 0.007 CID_154699841 | CID_154699841 | |
| 0.255 | 0.151 | 0.255 | Antiobesity | 0.217 0.19 CID_154699841 | ||
| 0.126 | 0.022 | 0.171 | Transcription factor NF kappa B stimulant | 0.171 0.012 CID_154699841 | CID_154699841 | |
| 0.106 | 0.004 | 0.106 | Lipocortins synthesis agonist | 0.099 0.005 CID_154699841 | ||
| 0.148 | 0.049 | 0.148 | Aldehyde dehydrogenase inhibitor | |||
| 0.187 | 0.088 | 0.187 | Insulin sensitizer | |||
| 0.159 | 0.061 | 0.159 | CF transmembrane conductance regulator agonist | |||
| 0.118 | 0.026 | 0.118 | Macrophage migration inhibitory factor inhibitor | |||
| 0.258 | 0.169 | 0.62 | Antibacterial | 0.62 0.016 CID_154699841 | CID_154699841 | |
| 0.092 | 0.004 | 0.092 | Progesterone agonist | 0.035 0.006 CID_154699841 | ||
| 0.156 | 0.069 | 0.156 | Phospholipase A2 inhibitor | 0.14 0.086 CID_154699841 | ||
| 0.132 | 0.044 | 0.166 | Photosensitizer | 0.166 0.023 CID_154699841 | CID_154699841 | |
| 0.175 | 0.094 | 0.175 | Growth factor agonist | |||
| 0.085 | 0.005 | 0.085 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.067 0.006 CID_154699841 | ||
| 0.085 | 0.005 | 0.085 | Farnesoid X receptor agonist | |||
| 0.122 | 0.042 | 0.16 | Toll-Like receptor 4 antagonist | 0.16 0.016 CID_154699841 | CID_154699841 | |
| 0.112 | 0.032 | 0.112 | Ornithine decarboxylase inhibitor | 0.075 0.073 CID_154699841 | ||
| 0.083 | 0.005 | 0.083 | Pregnane X receptor antagonist | |||
| 0.09 | 0.014 | 0.091 | Nitric oxide donor | 0.091 0.014 CID_154699841 | CID_154699841 | |
| 0.156 | 0.081 | 0.156 | Sigma receptor agonist | |||
| 0.085 | 0.012 | 0.085 | Heme oxygenase stimulant | 0.069 0.027 CID_154699841 | ||
| 0.074 | 0.005 | 0.074 | Microtubule stabilization | 0.065 0.01 CID_154699841 | ||
| 0.075 | 0.007 | 0.075 | Dopamine D5 agonist | |||
| 0.11 | 0.042 | 0.221 | Antineoplastic antibiotic | 0.221 0.018 CID_154699841 | CID_154699841 | |
| 0.124 | 0.06 | 0.133 | Protein-tyrosine phosphatase 1B inhibitor | 0.133 0.054 CID_154699841 | CID_154699841 | |
| 0.205 | 0.142 | 0.205 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.093 | 0.032 | 0.093 | CDC25A inhibitor | |||
| 0.064 | 0.006 | 0.064 | Glucose-6-phosphate dehydrogenase inhibitor | 0.046 0.015 CID_154699841 | ||
| 0.109 | 0.051 | 0.109 | Hedgehog signaling inhibitor | 0.101 0.063 CID_154699841 | ||
| 0.057 | 0.001 | 0.057 | Transcortin receptor antagonist | 0.007 0.004 CID_154699841 | ||
| 0.176 | 0.12 | 0.313 | Platelet antagonist | 0.313 0.048 CID_154699841 | CID_154699841 | |
| 0.07 | 0.017 | 0.07 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.107 | 0.056 | 0.107 | Bronchodilator | |||
| 0.12 | 0.07 | 0.12 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.179 | 0.13 | 0.181 | Nitric-oxide synthase stimulant | 0.181 0.126 CID_154699841 | CID_154699841 | |
| 0.129 | 0.082 | 0.129 | Neurotrophic factor | |||
| 0.05 | 0.005 | 0.05 | Estrogen-related receptor beta antagonist | |||
| 0.124 | 0.079 | 0.143 | Interleukin 4 antagonist | 0.143 0.056 CID_154699841 | CID_154699841 | |
| 0.135 | 0.091 | 0.241 | Insulin secretagoues | 0.241 0.021 CID_154699841 | CID_154699841 | |
| 0.091 | 0.046 | 0.091 | Inducible nitric-oxide synthase inhibitor | |||
| 0.078 | 0.037 | 0.078 | Elastase 1 inhibitor | |||
| 0.055 | 0.015 | 0.055 | Liver X receptor alpha agonist | |||
| 0.044 | 0.005 | 0.044 | Glucocorticoid agonist | 0.011 0.01 CID_154699841 | ||
| 0.165 | 0.129 | 0.28 | Cyclic AMP phosphodiesterase inhibitor | 0.28 0.05 CID_154699841 | CID_154699841 | |
| 0.038 | 0.004 | 0.041 | Ileal bile acid transport inhibitor | 0.041 0.004 CID_154699841 | CID_154699841 | |
| 0.037 | 0.003 | 0.037 | Vitamin D receptor agonist | 0.023 0.005 CID_154699841 | ||
| 0.042 | 0.008 | 0.042 | Elastase 2B inhibitor | 0.031 0.021 CID_154699841 | ||
| 0.042 | 0.008 | 0.042 | Elastase 3A inhibitor | 0.031 0.021 CID_154699841 | ||
| 0.042 | 0.008 | 0.042 | Elastase 3B inhibitor | 0.031 0.021 CID_154699841 | ||
| 0.085 | 0.051 | 0.085 | Opioid kappa receptor antagonist | |||
| 0.055 | 0.021 | 0.055 | Opioid kappa receptor agonist | |||
| 0.038 | 0.005 | 0.038 | Hedgehog signaling activator | |||
| 0.036 | 0.005 | 0.036 | Corticosteroid-like | 0.034 0.005 CID_154699841 | ||
| 0.131 | 0.1 | 0.134 | Protein-tyrosine phosphatase inhibitor | 0.134 0.096 CID_154699841 | CID_154699841 | |
| 0.043 | 0.016 | 0.043 | Estrogen-related receptor alpha antagonist | |||
| 0.049 | 0.023 | 0.049 | Parathyroid hormone antagonist | |||
| 0.064 | 0.038 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.037 CID_154699841 | CID_154699841 | |
| 0.056 | 0.031 | 0.149 | Heparanase inhibitor | 0.149 0.003 CID_154699841 | CID_154699841 | |
| 0.097 | 0.073 | 0.217 | Topoisomerase I inhibitor | 0.217 0.023 CID_154699841 | CID_154699841 | |
| 0.039 | 0.016 | 0.039 | Tubulin agonist | |||
| 0.05 | 0.029 | 0.05 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.087 | 0.067 | 0.102 | Thioredoxin inhibitor | 0.102 0.046 CID_154699841 | CID_154699841 | |
| 0.023 | 0.005 | 0.028 | Telomerase stimulant | 0.028 0.003 CID_154699841 | CID_154699841 | |
| 0.037 | 0.019 | 0.037 | HMG CoA reductase inhibitor | |||
| 0.027 | 0.011 | 0.03 | Dopamine D1 agonist | 0.03 0.009 CID_154699841 | CID_154699841 | |
| 0.021 | 0.007 | 0.021 | NMDA receptor phencyclidine site antagonist | |||
| 0.056 | 0.044 | 0.056 | Botulinum neurotoxin type A inhibitor | |||
| 0.021 | 0.01 | 0.021 | Progesterone receptor B antagonist | |||
| 0.015 | 0.004 | 0.015 | Progesterone receptor A antagonist | |||
| 0.038 | 0.029 | 0.038 | GABA uptake inhibitor | |||
| 0.082 | 0.073 | 0.106 | ATPase (Vacuolar H+) inhibitor | 0.106 0.032 CID_154699841 | CID_154699841 | |
| 0.014 | 0.006 | 0.014 | 3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor | |||
| 0.097 | 0.089 | 0.256 | Topoisomerase II inhibitor | 0.256 0.024 CID_154699841 | CID_154699841 | |
| 0.069 | 0.062 | 0.189 | Topoisomerase II alpha inhibitor | 0.189 0.017 CID_154699841 | CID_154699841 | |
| 0.021 | 0.017 | 0.021 | Vitamin D receptor antagonist | |||
| 0.1 | 0.097 | 0.1 | Interleukin 8 antagonist | |||
| 0.055 | 0.054 | 0.055 | Ryanodine receptor antagonist | |||
| 0.051 | 0.049 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.101 | 0.1 | 0.111 | Alpha-N-acetylglucosaminidase inhibitor | 0.111 0.087 CID_154699841 | CID_154699841 | |
| 0.062 | 0.061 | 0.062 | Glutamate (mGluR6) antagonist | |||
| 0.082 | 0.085 | 0.099 | Glutamate release inhibitor | 0.099 0.045 CID_154699841 | CID_154699841 | |
| 0.087 | 0.094 | 0.145 | Beta glucuronidase inhibitor | 0.145 0.027 CID_154699841 | CID_154699841 | |
| 0.044 | 0.053 | 0.079 | Glucose-6-phosphate translocase inhibitor | 0.079 0.012 CID_154699841 | CID_154699841 | |
| 0.039 | 0.055 | 0.104 | Protein 50S ribosomal subunit inhibitor | 0.104 0.012 CID_154699841 | CID_154699841 | |
| 0.022 | 0.045 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_154699841 | CID_154699841 | |
| 0.019 | 0.044 | 0.029 | Vanilloid 2 agonist | 0.029 0.011 CID_154699841 | CID_154699841 | |
| 0.074 | 0.102 | 0.117 | UDP-glucose 4-epimerase inhibitor | 0.117 0.045 CID_154699841 | CID_154699841 | |
| 0.013 | 0.044 | 0.024 | Antibiotic Anthracycline-like | 0.024 0.006 CID_154699841 | CID_154699841 | |
| 0.003 | 0.041 | 0.013 | Antibiotic Macrolide-like | 0.013 0.011 CID_154699841 | CID_154699841 | |
| 0.017 | 0.057 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 CID_154699841 | CID_154699841 | |
| 0.167 | 0.207 | 0.366 | Immunomodulator | 0.366 0.055 CID_154699841 | CID_154699841 | |
| 0.014 | 0.059 | 0.035 | Sodium/glucose cotransporter 2 inhibitor | 0.035 0.01 CID_154699841 | CID_154699841 | |
| 0.113 | 0.16 | 0.142 | CC chemokine 6 receptor antagonist | 0.142 0.035 CID_154699841 | CID_154699841 | |
| 0.078 | 0.126 | 0.163 | Multidrug resistance-associated protein 1 inhibitor | 0.163 0.02 CID_154699841 | CID_154699841 | |
| 0.019 | 0.069 | 0.032 | Toll-Like receptor 4 agonist | 0.032 0.01 CID_154699841 | CID_154699841 | |
| 0.024 | 0.078 | 0.068 | Antibiotic Aminoglycoside-like | 0.068 0.006 CID_154699841 | CID_154699841 | |
| 0.013 | 0.07 | 0.047 | Protein 30S ribosomal subunit inhibitor | 0.047 0.009 CID_154699841 | CID_154699841 | |
| 0.084 | 0.154 | 0.261 | Thrombolytic | 0.261 0.031 CID_154699841 | CID_154699841 | |
| 0.009 | 0.082 | 0.033 | Arginase inhibitor | 0.033 0.028 CID_154699841 | CID_154699841 | |
| 0.06 | 0.134 | 0.081 | Triose-phosphate isomerase inhibitor | 0.081 0.074 CID_154699841 | CID_154699841 | |
| 0.099 | 0.173 | 0.344 | Hemostatic | 0.344 0.012 CID_154699841 | CID_154699841 | |
| 0.113 | 0.192 | 0.206 | ATPase inhibitor | 0.206 0.032 CID_154699841 | CID_154699841 | |
| 0.029 | 0.114 | 0.052 | Alpha-mannosidase inhibitor | 0.052 0.04 CID_154699841 | CID_154699841 | |
| 0.031 | 0.117 | 0.063 | Phosphofructokinase-1 inhibitor | 0.063 0.054 CID_154699841 | CID_154699841 | |
| 0.138 | 0.233 | 0.354 | Peptidyltransferase inhibitor | 0.354 0.011 CID_154699841 | CID_154699841 | |
| 0.027 | 0.123 | 0.289 | Selectin antagonist | 0.289 0.006 CID_154699841 | CID_154699841 | |
| 0.039 | 0.136 | 0.056 | Adenine nucleotide translocase inhibitor | 0.056 0.036 CID_154699841 | CID_154699841 | |
| 0.034 | 0.14 | 0.062 | Neuraminidase (influenza) inhibitor | 0.062 0.048 CID_154699841 | CID_154699841 | |
| 0.05 | 0.172 | 0.087 | Uric acid excretion stimulant | 0.087 0.07 CID_154699841 | CID_154699841 | |
| 0.063 | 0.228 | 0.257 | Cell adhesion inhibitor | 0.257 0.014 CID_154699841 | CID_154699841 | |
| 0.036 | 0.24 | 0.122 | DNA intercalator | 0.122 0.056 CID_154699841 | CID_154699841 | |
| 0.048 | 0.329 | 0.145 | Cell wall synthesis inhibitor | 0.145 0.07 CID_154699841 | CID_154699841 | |
| 0.014 | 0.609 | 0.146 | Anticoagulant | 0.146 0.084 CID_154699841 | CID_154699841 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |